Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.67 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.67 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.67 |
| ▸ | TOP2B | Q02880 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | POLB | P06746 | 2/20 | 0.57 |
| ▸ | BLM | P54132 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | EGFR | P00533 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | RAD52 | P43351 | 1/20 | 0.57 |
| ▸ | RECQL | P46063 | 1/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | NSD2 | O96028 | 3/20 | 0.55 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30818304 | 1.00 | SMN1; SMN2 (0.67) | SMN1; SMN2BRCA1HIF1ATOP2BMEN1 | |
| SCHEMBL6812028 | 0.94 | SMN1; SMN2 (0.62) | SMN1; SMN2BRCA1HIF1ATOP2BMEN1 | |
| Hydrochloric Acid SCHEMBL4872203 | 0.93 | SMN1; SMN2 (0.60) | SMN1; SMN2BRCA1HIF1ATOP2BMEN1 | |
| SCHEMBL10046650 | 0.92 | SMN1; SMN2 (0.73) | SMN1; SMN2BRCA1HIF1ATOP2BMEN1 | |
| SCHEMBL2482880 | 0.92 | SMN1; SMN2 (0.59) | SMN1; SMN2BRCA1HIF1ATOP2BMEN1 | |
| SCHEMBL20482316 | 0.92 | SMN1; SMN2 (0.59) | SMN1; SMN2BRCA1HIF1ATOP2BMEN1 | |
| SCHEMBL31218590 | 0.90 | MALT1 (0.62) | SMN1; SMN2BRCA1HIF1ATOP2BMEN1 | |
| SCHEMBL29587040 | 0.90 | MALT1 (0.62) | SMN1; SMN2BRCA1HIF1ATOP2BMEN1 | |
| SCHEMBL7557626 | 0.90 | MALT1 (0.62) | SMN1; SMN2BRCA1HIF1ATOP2BMEN1 | |
| SCHEMBL31218593 | 0.90 | MAPT (0.71) | SMN1; SMN2BRCA1HIF1ATOP2BMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230181768-A1 | TISSUE-TARGETING COMPLEX | PHARMPUR GMBH (DE) | 2023-06-15 | — | — | US | disclosed |
| US-10263308-B2 | Solar flow battery | CORNELL UNIVERSITY (US) | 2019-04-16 | — | — | US | disclosed |
| US-10079401-B2 | Symmetric redox flow battery containing organic redox active molecule | CORNELL UNIVERSITY (US) | 2018-09-18 | — | — | US | disclosed |
| US-20170187059-A1 | SYMMETRIC REDOX FLOW BATTERY CONTAINING ORGANIC REDOX ACTIVE MOLECULE | CORNELL UNIVERSITY (US) | 2017-06-29 | — | — | US | disclosed |
| US-20170179558-A1 | SOLAR FLOW BATTERY | CORNELL UNIVERSITY (US) | 2017-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230181768-A1 | TISSUE-TARGETING COMPLEX | ALK, CLTB, ACVR1B | SMN1; SMN2 1838/4885BRCA1 3407/4885HIF1A 3473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.